Sanitary scandal in Poitiers: "If it's not clinical trial, I do not know what it is ...", denounces the director of the Alzheimer's Foundation
At the microphone of Europe 1, the director of the Alzheimer's Foundation & nbsp; Philippe Amouyel & nbsp; is formal: the tests carried out illegally by the Professor Henri Joyeux on patients with Alzheimer or Parkinson in an abbey close to Poitiers are good and well a clinical trial. & nbsp;
At the microphone of Europe 1, the director of the Alzheimer Foundation Philippe Amouyel is formal: the tests carried out illegally by Professor Henri Joyeux on patients with Alzheimer's or Parkinson's in an abbey near Poitiers are good and well a test clinical.
New health scandal revealed Thursday. A "wild" clinical trial, and therefore illegal, conducted on at least 350 Parkinson's or Alzheimer's patients, was banned by the ANSM, the National Agency for Safety of Medicines and Health Products, which qualified the practice of close to quackery. A statement shared by Professor Philippe Amouyel, doctor and researcher specializing in diseases of aging at Lille University Hospital, and director of the Alzheimer Foundation.
"It has all the characteristics, without the rigorous conditions imposed for the protection of people"
"I agree with the health authorities," says the specialist. During this trial, patients were welcomed in an abbey near Poitiers to be patched with a molecule that was supposed to treat their disease, before taking a blood test the next day. These practices led by the Josefa Fund have not prevented the controversial professor Henri Joyeux, known for his battle against vaccines, at the head of the project, to say on Europe 1 that this "has nothing to do with a study. clinical".
"Even if Henri Joyeux says no, if it's not a clinical trial, I do not know what it is ... It has all the characteristics, without the rigorous conditions imposed for the protection of people who "It's a clinical trial," says the director of the Alzheimer's Foundation. "Before you can use a molecule, you need data that confirms its interest and safety in the animal.There is an extremely important process to ensure that, if at any time, the molecule has an adverse effect or other, we can immediately stop the test, "says the expert. "All the elements are not in this file".